ImageneBio, Inc. (IMA) Institutional Ownership

Ownership Summary

A total of 39 institutions have reported a stake in ImageneBio, Inc. (NASDAQ:IMA) as of December 2025, according to recent 13F filings with the SEC.

• These investors collectively held 53.8% of the company's total shares outstanding in December 2025, up from 53.4% in September 2025.
• In percentage terms, this reflects as a holdings change of 38.41% quarter on quarter, and a decrease of 26.42% year over year.
• Among the 39 institutional holders of ImageneBio, 26 added to their stakes while 3 trimmed their positions and 10 held steady.
• The total number of shares held by institutions in ImageneBio increased to 4.74Mn as of December 2025, a net change of up by 1.31Mn shares quarter on quarter, and down 26.96Mn shares year over year.
• As of December 31, 2025, Blue Owl Capital Holdings LP held ImageneBio's largest shareholding position with over 823.78K shares, representing 9.35% of total outstanding shares.
• Among the most significant buyers of ImageneBio during December 2025 were Cable Car Capital, LP (643.93K), Blue Owl Capital Holdings LP (282.86K), Monashee Investment Management LLC (91.62K), BlackRock, Inc. (79.48K), DRW Securities, LLC (43.77K).
• Leading sellers of ImageneBio stock in December 2025 included CITADEL ADVISORS LLC (35.77K), BML Capital Management, LLC (5.48K), Aldebaran Capital, LLC (492).
• The top 10 institutional holders of ImageneBio for the quarter ending December 2025 included Blue Owl Capital Holdings LP (823.78K), BVF INC/IL (802.10K), Cable Car Capital, LP (643.93K), Omega Fund Management, LLC (455.36K), ORBIMED ADVISORS LLC (378.56K), RTW INVESTMENTS, LP (334.44K), VANGUARD GROUP INC (238.00K), BML Capital Management, LLC (177.03K), BlackRock, Inc. (131.59K), Monashee Investment Management LLC (91.62K).